TGFBR2 and thyroid cancer: We validated the downregulation of SNAI2, SOX4, and TGFBR2, three targets never investigated in thyroid cancer cells, and of HMGA2, a miR-2 04-5p target previously identified in the lab (unpublished results), in TPC-1 and BCPAP cells following miR-204-5p overexpression.